Growth Hormone-Releasing Peptide-2
For Pulsatile Growth Hormone Research
โ ๏ธ Important: This information is for educational and research purposes only. Always consult with a qualified healthcare professional before use.
๐ Contents
GHRP-2 (Growth Hormone-Releasing Peptide-2) is a synthetic hexapeptide (D-Ala-D-ฮฒ-Nal-Ala-Trp-D-Phe-Lys-NH2) that acts as a potent growth hormone secretagogue receptor (GHSR) agonist . It is a second-generation growth hormone-releasing peptide that stimulates the pituitary gland to release endogenous growth hormone in a pulsatile manner .
GHRP-2 was developed as an improvement over GHRP-6 with increased potency and a more favorable side-effect profile . It is approximately 3-5 times more potent than GHRP-6 in stimulating GH release . GHRP-2 is available in pen and freeze-dried vial formulations for research purposes.
GHRP-2 works through a targeted mechanism to stimulate natural growth hormone release:
Binds to growth hormone secretagogue receptor (GHSR) on pituitary somatotroph cells
Stimulates natural pulsatile growth hormone secretion pattern
3-5x more potent than GHRP-6 with a more favorable side-effect profile
GHRP-2 is often combined with a GHRH analog (such as CJC-1295 or Sermorelin) for enhanced synergistic GH release .
Studying pulsatile GH secretion and IGF-1 elevation
Researching muscle growth, recovery, and protein synthesis
Investigating lipolysis, fat metabolism, and energy balance
Synergistic effects with GHRH analogs (CJC-1295, Sermorelin)
Growth Hormone Secretagogue Activity
Combination Therapy
Key Research Findings
Select your vial size and dose to see the corresponding volume, clicks, dosing frequency, and how many doses per vial:
๐๏ธ Step 1: Select Your Vial Size
๐ Step 2: Select Your Dose
Common research protocols: 50-300 mcg per injection, 1-3 times daily
Vial Size
10mg Vial
Selected Dose
100 mcg
Doses per Vial
100 doses
Pen Clicks
3 clicks
Volume
0.03 mL
Protocol Level
Level 2 (Standard)
Recommended Schedule
1-3 times daily - Pulsatile Protocol
โ ๏ธ Do not change your dose unless advised by a qualified professional.
๐ Protocol Level Summary
Based on research protocols: 50-300 mcg per injection, 1-3 times daily. GHRP-2 is 3-5x more potent than GHRP-6.
| Protocol Level | Target Dose | Frequency | Pen Clicks | Volume (mL) | Who It\'s For |
|---|---|---|---|---|---|
| Level 1 (Starting) | 50 mcg | 1-3x daily | 1.5 clicks | 0.015 mL | New users, first 2 weeks |
| Level 2 (Standard) | 100 mcg | 1-3x daily | 3 clicks | 0.03 mL | After 2 weeks, maintenance |
| Level 3 (Advanced) | 150-200 mcg | 1-3x daily | 4.5-6 clicks | 0.045-0.06 mL | If more response needed |
| Level 4 (Maximum) | 300 mcg | 1-3x daily | 9 clicks | 0.09 mL | Experienced users only |
โ ๏ธ Do not change your dose unless advised by a qualified professional.
๐ Vial Users (Insulin Syringe)
Add 3mL of bacteriostatic water to your freeze-dried vial and mix gently. After reconstitution, use the table below to draw your dose:
Vial Size
10mg vial with 3mL bac water
| Dose | Frequency | Units on Syringe | Volume (mL) | Protocol Level |
|---|
โ ๏ธ Always use a new sterile needle and syringe for each injection.
GHRP-2 is generally well-tolerated at recommended doses. Compared to GHRP-6, it has a more favorable side-effect profile .
Important Safety Considerations:
โ ๏ธ Warning: GHRP-2 is an investigational peptide with limited human safety data. If you experience severe allergic reactions, difficulty breathing, or signs of anaphylaxis, seek immediate medical help.
This information is for educational and research purposes only. Always consult with a qualified healthcare professional.
Last updated: July 2026
โ ๏ธ FOR RESEARCH PURPOSES ONLY